Felicia Ceban

3.7k total citations · 2 hit papers
49 papers, 2.2k citations indexed

About

Felicia Ceban is a scholar working on Biological Psychiatry, Pharmacology and Neurology. According to data from OpenAlex, Felicia Ceban has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Biological Psychiatry, 20 papers in Pharmacology and 13 papers in Neurology. Recurrent topics in Felicia Ceban's work include Tryptophan and brain disorders (21 papers), Treatment of Major Depression (18 papers) and Long-Term Effects of COVID-19 (13 papers). Felicia Ceban is often cited by papers focused on Tryptophan and brain disorders (21 papers), Treatment of Major Depression (18 papers) and Long-Term Effects of COVID-19 (13 papers). Felicia Ceban collaborates with scholars based in Canada, Singapore and China. Felicia Ceban's co-authors include Joshua D. Rosenblat, Roger S. McIntyre, Leanna M.W. Lui, Roger Ho, Joshua D. Di Vincenzo, Yena Lee, Mehala Subramaniapillai, Bing Cao, Kayla M. Teopiz and Hartej Gill and has published in prestigious journals such as Brain, Neuroscience & Biobehavioral Reviews and Molecular Biology of the Cell.

In The Last Decade

Felicia Ceban

47 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis

2021 871 citations Felicia Ceban, Susan Ling et al. Brain Behavior and Immunity profile →
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

2021 241 citations Leanna M.W. Lui, Felicia Ceban et al. Journal of Psychiatric Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felicia Ceban Canada	21	1.1k	939	456	360	350	49	2.2k
Joshua D. Di Vincenzo Canada	18	990 0.9×	749 0.8×	399 0.9×	424 1.2×	468 1.3×	44	2.0k
Kayla M. Teopiz Canada	25	913 0.9×	1.1k 1.2×	547 1.2×	551 1.5×	626 1.8×	145	2.8k
Kangguang Lin China	29	975 0.9×	1.1k 1.2×	879 1.9×	499 1.4×	495 1.4×	96	3.3k
Nelson B. Rodrigues Canada	25	909 0.9×	919 1.0×	534 1.2×	765 2.1×	860 2.5×	75	2.7k
Luca Steardo Italy	32	510 0.5×	598 0.6×	524 1.1×	322 0.9×	654 1.9×	106	3.1k
Chih‐Sung Liang Taiwan	28	248 0.2×	360 0.4×	1.0k 2.3×	244 0.7×	234 0.7×	236	2.8k
Ming‐Chyi Huang Taiwan	27	215 0.2×	348 0.4×	618 1.4×	430 1.2×	295 0.8×	166	2.5k
Philip Gerretsen Canada	33	196 0.2×	464 0.5×	1.6k 3.4×	457 1.3×	282 0.8×	173	3.7k
Manit Srisurapanont Thailand	30	329 0.3×	677 0.7×	1.4k 3.0×	180 0.5×	708 2.0×	126	3.6k
Stanley N. Caroff United States	37	809 0.8×	553 0.6×	3.3k 7.2×	273 0.8×	1.4k 3.9×	121	5.0k

Countries citing papers authored by Felicia Ceban

Since Specialization

Citations

This map shows the geographic impact of Felicia Ceban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicia Ceban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicia Ceban more than expected).

Fields of papers citing papers by Felicia Ceban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicia Ceban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicia Ceban. The network helps show where Felicia Ceban may publish in the future.

Co-authorship network of co-authors of Felicia Ceban

This figure shows the co-authorship network connecting the top 25 collaborators of Felicia Ceban. A scholar is included among the top collaborators of Felicia Ceban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicia Ceban. Felicia Ceban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Le, Gia Han, Angela T.H. Kwan, Sabrina Wong, et al.. (2025). Impact of Fatigue on Subjective and Objective Cognitive Functions in Persons with Post-COVID-19 Condition. Clinical Nursing Research. 34(3-4). 143–152.

Ceban, Felicia, Aparna Saripella, Ellene Yan, et al.. (2024). Adverse events in patients with obstructive sleep apnea undergoing procedural sedation in ambulatory settings: An updated systematic review and meta-analysis. Sleep Medicine Reviews. 80. 102029–102029.

Tamura, Jocelyn K., Nelson B. Rodrigues, Rodrigo B. Mansur, et al.. (2024). The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder. CNS Spectrums. 29(6). 697–704. 3 indexed citations

Le, Gia Han, Angela T.H. Kwan, Sabrina Wong, et al.. (2024). Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis. Acta Neuropsychiatrica. 36(4). 211–217. 1 indexed citations

Rhee, Taeho Greg, Felicia Ceban, Roger Ho, et al.. (2023). Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials. CNS Drugs. 37(10). 867–881. 22 indexed citations

Wu, Jie, Angela T.H. Kwan, Taeho Greg Rhee, et al.. (2023). A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia. Expert Review of Clinical Pharmacology. 16(11). 1085–1092. 3 indexed citations

Ceban, Felicia, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.. (2023). COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behavior and Immunity. 111. 211–229. 65 indexed citations

Cooper, Daniel, Felicia Ceban, Joshua D. Di Vincenzo, et al.. (2023). Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review. Journal of Psychiatric Research. 164. 80–89. 46 indexed citations

Meshkat, Shakila, Roger Ho, Bing Cao, et al.. (2022). Biomarkers of ketamine's antidepressant effect: An umbrella review. Journal of Affective Disorders. 323. 598–606. 12 indexed citations

10.

Jawad, Muhammad Youshay, Joshua D. Di Vincenzo, Felicia Ceban, et al.. (2022). The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis. Expert Opinion on Drug Safety. 21(6). 841–852. 17 indexed citations

11.

Meshkat, Shakila, Leanna M.W. Lui, Roger Ho, et al.. (2022). The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review. Journal of Psychiatric Research. 149. 252–259. 20 indexed citations

12.

Alnefeesi, Yazen, David Chen‐Li, Muhammad Youshay Jawad, et al.. (2022). Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis. Journal of Psychiatric Research. 151. 693–709. 109 indexed citations

13.

Lui, Leanna M.W., Felicia Ceban, Kayla M. Teopiz, et al.. (2022). Immune response to vaccination in adults with mental disorders: A systematic review. Journal of Affective Disorders. 304. 66–77. 20 indexed citations

14.

Lee, Yena, Joshua D. Di Vincenzo, Felicia Ceban, et al.. (2022). Active mechanisms of ketamine-assisted psychotherapy: A systematic review. Journal of Affective Disorders. 315. 105–112. 24 indexed citations

15.

Meshkat, Shakila, Joshua D. Rosenblat, Roger Ho, et al.. (2022). Ketamine use in pediatric depression: A systematic review. Psychiatry Research. 317. 114911–114911. 9 indexed citations

16.

Ling, Susan, Leanna M.W. Lui, Kayla M. Teopiz, et al.. (2022). Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment. Expert Opinion on Drug Safety. 21(6). 733–743. 11 indexed citations

17.

Ceban, Felicia, Joshua D. Rosenblat, Kevin Kratiuk, et al.. (2021). Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders. CNS Drugs. 35(9). 925–934. 55 indexed citations

18.

Ceban, Felicia, Susan Ling, Leanna M.W. Lui, et al.. (2021). Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behavior and Immunity. 101. 93–135. 871 indexed citations breakdown →

19.

Meshkat, Shakila, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.. (2021). Pharmacogenomics of ketamine: A systematic review. Journal of Psychiatric Research. 145. 27–34. 22 indexed citations

20.

Alnefeesi, Yazen, Jocelyn K. Tamura, Leanna M.W. Lui, et al.. (2021). Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neuroscience & Biobehavioral Reviews. 131. 192–210. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact